Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. [electronic resource]
- Lancet (London, England) Oct 2001
- 1239-41 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
0140-6736
10.1016/S0140-6736(01)06355-3 doi
Antineoplastic Agents--therapeutic use Child Disease-Free Survival Female Hematopoietic Stem Cell Transplantation Humans Male Neoplasm, Residual Polymerase Chain Reaction Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy Predictive Value of Tests Prognosis Retrospective Studies